Fortress Biotech Inc

NASDAQ:FBIO   3:59:39 PM EDT
0.83
-0.01 (-1.33%)
Earnings Announcements

Fortress Biotech Reports Q1 2022 Results

Published: 05/12/2022 20:21 GMT
Fortress Biotech Inc (FBIO) - Fortress Biotech Reports First Quarter 2022 Financial Results and Recent Corporate Highlights.
Q1 Revenue Rose 106 Percent to $23.9 Million.
Qtrly Net Loss per Common Share Attributable to Common Stockholders $(0.18.
Q1 Earnings per Share View $-0.28, Revenue View $20.7 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $23.24 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $24.13 Million
Next Quarter EPS Guidance is expected to be -$0.17

More details on our Analysts Page.